TITLE

Salmeterol tachyphylaxis in steroid treated asthmatic subjects

AUTHOR(S)
Booth, H; Bish, R; Walters, J; Whitehead, F; Walters, E H
PUB. DATE
November 1996
SOURCE
Thorax;Nov1996, Vol. 51 Issue 11, p1100
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66016103

 

Related Articles

  • Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis. Stockley, Robert A.; Whitehead, Philip J.; Williams, Michael K. // Respiratory Research;2006, Vol. 7, p147 

    Background: Several studies have demonstrated that long-acting β2-agonists such as salmeterol are beneficial in chronic obstructive pulmonary disease (COPD). A meta-analysis was therefore conducted to review studies in COPD to provide pooled estimates of the effect of salmeterol 50 mcg taken...

  • Salmeterol.  // Reactions Weekly;9/2/2006, Issue 1117, p21 

    The article discusses research on the use of Salmeterol for treating two adolescent boys' acute asthmatic episodes. They were receiving inhaled corticosteroids and salmeterol as maintenance therapy. Loss of consciousness, cyanosis and repeated calls for emergency care happen when they have asthma.

  • Effect of long term treatment with salmeterol on asthma control: A double blind, randomised... Wilding, Paul; Clark, Miranda // BMJ: British Medical Journal (International Edition);05/17/97, Vol. 314 Issue 7092, p1441 

    Studies the effect of long term treatment with salmeterol on asthma management. Details of the crossover method used in the study; Subjects' adjustment of inhaled steroid dose according to a management plan based on peak flow recordings and symptoms; Reduction of inhaled steroid doses;...

  • GPs failing to heed official advice on asthma prescribing. Gough, Rob // Pulse;9/29/2003, Vol. 63 Issue 39, p10 

    Reports on the refusal of general practitioners to heed the ruling of the Great Britain Committee on Safety of Medicines on prescribing inhaled steroids alongside long-acting beta antagonists in asthmatics. Reaction to increased asthma-related deaths due to salmeterol use; Citation of legal...

  • Salmeterol and fluticasone propionate given as a combination: Lack of systemic pharmacodynamic and pharmacokinetic interactions. Kirby, S.; Falcoz, C.; Daniel, M. J.; Milleri, S.; Squassante, L.; Ziviani, L.; Ventresca, G. P. // European Journal of Clinical Pharmacology;Jan/Feb2001, Vol. 56 Issue 11, p781 

    Objective: To investigate the potential for systemic pharmacodynamic and pharmacokinetic interactions between inhaled salmeterol and fluticasone propionate when repeat doses of the two drugs are given in combination to healthy subjects. Methods: Twenty-eight healthy subjects received salmeterol...

  • Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Redington, A. E.; Meng, Q-H.; Springall, D. R.; Evans, T. J.; Créminon, C.; Maclouf, J.; Holgate, S. T.; Howarth, P. H.; Polak, J. M. // Thorax;May2001, Vol. 56 Issue 5, p351 

    Background-Nitric oxide (NO) and prostanoids are mediators of vascular and bronchial tone that are postulated to be involved in asthma. Increased levels of both are found in asthmatic subjects and are synthesised by enzymes that have cytokine inducible forms: inducible NO synthase (iNOS) and...

  • Should tiotropium be a maintenance asthma medication?  // Primary Care Reports;Jan2011 Clinical Briefs in Primary, Vol. 16 Issue 1, p2 

    The article reports on a research study on asthmatics treated either with, or in combination with inhaled corticosteroids (ICS), tiotropium (TIO), or long-acting beta agonist salmeterol (LABA), concluding that TIO in conjunction with ICS is a good maintenance medication for asthma.

  • Side effect solution. Nash, Karen // Dermatology Times;Jan2011, Vol. 32 Issue 1, p37 

    The article discusses the complications of topical steroids in treating dermatitis. It notes that the potential effects include atrophy, rosacea, irritation, tachyphylaxis and allergy. According Doctor Stephen Wolverton, Theodore Arlook Professor of clinical dermatology at Indiana University...

  • Bronchial macrophages in asthmatics reveal decreased CD16 expression and substantial levels of receptors for IL-10, but not IL-4 and IL-7. Moniuszko, Marcin; Bodzenta-Łukaszyk, Anna; Kowal, Krzysztof; Dąbrowska, Milena // Folia Histochemica et Cytobiologica;2007, Vol. 45 Issue 3, p181 

    The role of different subpopulations of bronchial macrophages (BMs) in asthma pathogenesis has not yet been completely elucidated. In addition, little is known about potential in vivo responsiveness of BMs to pro- and anti-inflammatory cytokines present in the bronchial milieu. We aimed to...

  • Exhaled 8-isoprostane in childhood asthma. Shahid, Sukhbir K.; Kharitonov, Sergei A.; Wilson, Nicola M.; Bush, Andrew; Barnes, Peter J. // Respiratory Research;2005, Vol. 6, p79 

    Background: Exhaled breath condensate (EBC) is a non-invasive method to assess airway inflammation and oxidative stress and may be useful in the assessment of childhood asthma. Methods: Exhaled 8-isoprostane, a stable marker of oxidative stress, was measured in EBC, in children (5-17 years) with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics